BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2112166)

  • 1. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
    McLinn S
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
    McLinn S
    Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin.
    Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM
    Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo.
    Goldfarb J; Crenshaw D; O'Horo J; Lemon E; Blumer JL
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1780-3. PubMed ID: 3149884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mupirocin ointment in the treatment of secondarily infected dermatoses.
    Breneman DL
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical development of mupirocin.
    Pappa KA
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):873-9. PubMed ID: 2112164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Gisby J; Bryant J
    Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains.
    Dagan R; Bar-David Y
    Antimicrob Agents Chemother; 1992 Feb; 36(2):287-90. PubMed ID: 1605593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mupirocin: a new topical antibiotic.
    Leyden JJ
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mupirocin and erythromycin in the treatment of impetigo.
    Britton JW; Fajardo JE; Krafte-Jacobs B
    J Pediatr; 1990 Nov; 117(5):827-9. PubMed ID: 2121951
    [No Abstract]   [Full Text] [Related]  

  • 13. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.
    Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
    Morley PA; Munot LD
    Curr Med Res Opin; 1988; 11(2):142-8. PubMed ID: 3146465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is penicillin still the drug of choice for non-bullous impetigo?
    Feder HM; Abrahamian LM; Grant-Kels JM
    Lancet; 1991 Sep; 338(8770):803-5. PubMed ID: 1681172
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children.
    Rice TD; Duggan AK; DeAngelis C
    Pediatrics; 1992 Feb; 89(2):210-4. PubMed ID: 1734386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of mupirocin ointment in the treatment of impetigo.
    Leyden JJ
    Clin Pediatr (Phila); 1992 Sep; 31(9):549-53. PubMed ID: 1468173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current options for the treatment of impetigo in children.
    Sladden MJ; Johnston GA
    Expert Opin Pharmacother; 2005 Oct; 6(13):2245-56. PubMed ID: 16218885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of impetigo.
    VanRavenstein K; Durham CO; Williams TH; Smith W
    Nurse Pract; 2017 Mar; 42(3):40-44. PubMed ID: 28178083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
    Johnston C
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):797-8. PubMed ID: 1907980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.